Related Experiment Video
Updated: Dec 9, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 in Children and Adolescents with Endocrine Conditions
Eirini Kostopoulou1, Maria Güemes2, Pratik Shah3
1Division of Paediatric Endocrinology and Diabetes, University of Patras, Patras, Greece.
Insights
Children with endocrine disorders generally do not face high risks from COVID-19. Reviewing guidelines for managing pediatric endocrine conditions during the pandemic is crucial for effective care.
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic necessitates reviewing management strategies for vulnerable populations.
- While adult endocrine conditions and COVID-19 are increasingly studied, data on pediatric endocrinopathies are limited.
- Children are generally less severely affected by COVID-19, but specific risks for those with endocrine disorders require clarification.
Purpose of the Study:
- To compile and review recommendations for managing pediatric endocrine conditions during the COVID-19 pandemic.
- To assess the risk of severe COVID-19 presentation in children with endocrine disorders.
- To consider the psychological impact of the pandemic on these children.
Main Methods:
- Systematic review of guidelines from health organizations and endocrine associations.
- Analysis of emerging data on COVID-19 manifestations in children with endocrine conditions.
- Inclusion of psychological considerations for affected pediatric populations.
Main Results:
- Most children with endocrine disorders are not considered a high-risk group for severe COVID-19.
- Standard "sick day management rules" and seeking medical advice are sufficient for most cases.
- Psychological support is an important aspect of care during the pandemic.
Conclusions:
- Children with endocrine conditions can generally be managed with standard protocols during the COVID-19 pandemic.
- Proactive management and psychological support are key to addressing concerns.
- Further research may be needed to refine specific recommendations.
Abstract:
The rapid spread of coronavirus disease (COVID-19) worldwide justifies global effort to combat the disease but also the need to review effective preventive strategies and medical management for potentially high-risk populations during the pandemic. Data regarding the COVID-19 manifestations in adults with underlying endocrine conditions, especially diabetes mellitus, are increasingly emerging. Albeit children and adolescents are considered to be affected in a milder manner, paucity of information regarding COVID-19 in children who suffer from endocrinopathies is available. The present review comprehensively collects recommendations issued by various health organizations and endocrine associations for the management of pediatric endocrine conditions during the pandemic. Adhering to the specific "sick day management rules" and undelayed seeking for medical advice are only needed in most of the cases, as the vast majority of children with endocrine disorders do not represent a high-risk population for contamination or severe presentation of COVID-19. Psychological implications in these children and adolescents are also considered.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
The Endocrine System
What is the Endocrine System?
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Endocrine Signaling

